National Institutes of Health (NIH), National Cancer Institute
R&D Prioritization
The National Institutes of Health National Cancer Institute (NCI) uses Decision Lens to identify specific cancer vaccine target antigens for accelerated research. Using Decision Lens software, NCI developed a list of “ideal” cancer antigen criteria/characteristics and evaluated numerous representative antigens against those criteria for potential accelerated funding. Decision Lens enabled NCI to capture input from academia, industry and government in an un-biased and structured way, enabling NCI to devote critical resources towards the research that is most likely to succeed.
